ImpactRx's TabletImpact shows reps tablet's strengths

Share this article:

ImpactRx, a firm that measures the impact of promotional materials on physician prescribing behavior, has launched TabletImpact, an analytical tool for pharma sales representatives. The tool lets reps gauge the execution and effectiveness of a tablet-centric marketing campaign.

The company's consulting analytics division devised TabletImpact as a way to help clients tactically adjust their strategies,  optimizing the impact of the tablet on the HCP audience, says Brian Gibbs, ImpactRx's vice president, consulting analytics.

"Not only can we measure the overall impact of a tablet-delivered detail, but we are also able to drill down into the components of the detail to determine which messages are more effectively delivered with the tablet,” explains Gibbs.

Combining use of the company's ImpactData asset with its TabletImpact tool has led to a “dramatic increase” in the use of the tablet across an aggressive e-detailing landscape, according to ImpactRx's president and CEO, Greg Ellis, who calls the product a “best-in-class analytical solution.”

“Considering the substantial investment our clients have made in this technology, it is vital that its impact on physician prescribing behavior be effectively analyzed and evaluated,” Ellis adds.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.